PLD3 and Alzheimer disease: In agreement with the previous results, we observed a statistically significant decrease in PLD3 mRNA expression in the hippocampus, a vulnerable region to AD pathology, and also show that PLD3 is reduced across Braak & Braak stages indicating that PLD3 is somehow related to the progressive neurodegenerative processes of AD.